Biotech Distilled
Substack ↗ Subscribe
Subscribe Substack ↗ About

Home › Therapeutic areas › GI/Hepatology

GI/Hepatology (13 companies · 10 conditions)

Conditions

Celiac Disease 3 Eosinophilic Esophagitis 3 Rare Gastroparesis 2 Wilson's Disease 2 Rare Alcohol-Associated Liver Disease 1 Chronic Idiopathic Constipation 1 Inflammatory Bowel Disease 1 Irritable Bowel Syndrome with Constipation 1 Nausea and Vomiting 1 Short Bowel Syndrome 1 Rare

Companies

Ticker Company Therapeutic areas In GI/Hepatology Lead stage Programs
ABSI Absci DermatologyGI/Hepatology+1 1 Phase 1 6
ACRS Aclaris Therapeutics DermatologyGI/Hepatology+1 Rare 1 Phase 2 8
ALT Altimmune GI/HepatologyMetabolic+1 1 Phase 3 3
ANAB AnaptysBio DermatologyGI/Hepatology+2 Rare 2 Approved 6
APGE Apogee Therapeutics DermatologyGI/Hepatology+1 Rare 1 Phase 2 9
ARDX Ardelyx GI/HepatologyRenal 2 Approved 4
ENTX Entera Bio GI/HepatologyMetabolic Rare 1 Phase 2 4
ETON Eton Pharmaceuticals GI/HepatologyInfectious Disease+2 Rare 2 Approved 14
FBRX Forte Biosciences DermatologyGI/Hepatology 1 Phase 2 3
IMUX Immunic GI/HepatologyNeurology 1 Phase 3 4
PCSA Processa Pharmaceuticals GI/HepatologyImmunology+2 Rare 1 Phase 2 7
RARE Ultragenyx Pharmaceutical CardiovascularGI/Hepatology+2 Rare 1 Approved 12
VNDA Vanda Pharmaceuticals CardiovascularDermatology+6 Rare 2 Approved 29